Spleen

Spleen function modulation" does not refer to a specific molecule, receptor, or canonical drug target. Instead, it describes the process of altering the activity or role of the spleen—an organ that orchestrates both innate and adaptive immune responses through mechanisms such as pathogen clearance, cytokine production, antigen presentation, and coordination of immune cell activity[1][3][5]. The spleen contains various immune cells (B cells, T cells, macrophages) that express receptors like β2-adrenoceptor (β2-AR), α1/α2-adrenoceptors (AR), neuropeptide Y receptors (NPY-R), and Toll-like receptor 4 (TLR4)[1]. These molecular targets are involved in neural and humoral regulation within the spleen but "spleen function modulation" itself is not a single molecular entity. The term may be used in research contexts to describe strategies aimed at influencing splenic activity for therapeutic benefit—such as reducing inflammation via neural pathways or targeting splenic immune cell signaling—but it does not correspond to a unique protein or gene product[1][4]. Therefore, this entry is considered incorrect as a canonical drug target.